Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (unaudited)

v3.20.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
Jan. 31, 2020
Apr. 30, 2019
Current Assets    
Cash $ 442,863 $ 503,438
Accounts receivable 28,500
Inventory 123,306
Other current assets 22,330 100,000
Total Current Assets 616,999 603,438
Goodwill 2,468,902
Trademark 20,000
Other 3,851
TOTAL ASSETS 3,109,752 603,438
Current Liabilities    
Accounts payable 219,133 20,894
Accrued Expenses 43,069 15,116
Notes Payable 211,609
Due to Related Party 343,121
Common shares to be issued 754,700
Total Current Liabilities 816,932 790,710
Convertible debentures 450,000
Commitments and contingencies
Stockholders' Equity    
Series A Preferred Stock - shares authorized 2,200,000; outstanding 208,704 and 0; Series B Preferred Stock - shares authorized 4,300,000; outstanding 3,681,623 and 0 38,903
Common stock - shares authorized 500,000,000; outstanding 19,861,091 and 179,292 19,861 179
Additional paid-in capital 3,732,120 784,371
Accumulated deficit (1,948,064) (971,822)
Total Stockholders' Equity 1,842,820 (187,272)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,109,752 $ 603,438